Recent trends in research for Alzheimer’s disease therapeutics are very promising. Currently, a multi-pronged approach is being adopted and many novel strategies are being explored. The eventual goal is to reduce the symptoms by improving neurotransmission in the brain, which slows down disease progression. Scientists are trying to block β-amyloid plaque formation using monoclonal antibodies (mAbs) by harnessing the power of the immune system.
Marisol Herrera-RiveroGonzalo Emiliano